Contributors | |
Preface | |
Symptoms and Signs of Respiratory Disease | p. 1 |
Approach to the Patient | p. 3 |
Pulmonary Function and Cardiopulmonary Exercise Testing | p. 31 |
Evaluation of Pulmonary Diseases by Imaging | p. 48 |
Bronchoscopy, Transthoracic Needle Aspiration, and Related Procedures | p. 75 |
Impairment and Disability Evaluation | p. 96 |
Obstructive Lung Diseases | p. 103 |
Chronic Obstructive Pulmonary Disease: Overview | p. 105 |
Chronic Obstructive Pulmonary Disease: Epidemiology, Pathophysiology, Pathogenesis, Clinical Course, Management, and Rehabilitation | p. 118 |
Asthma | p. 143 |
Aspirin- and Exercise-Induced Asthma | p. 151 |
Allergic Bronchopulmonary Aspergillosis and Hypersensitivity Reactions to Fungi | p. 159 |
Upper Airway Obstruction | p. 165 |
Cystic Fibrosis | p. 176 |
Bronchiolitis | p. 187 |
Bullous Diseases of the Lung | p. 198 |
Occupational and Environmental Disorders | p. 203 |
Occupational Lung Disorders: General Principles and Approaches | p. 205 |
Asbestos-Related Lung Disease | p. 217 |
Chronic Beryllium and Hard-Metal Lung Disease | p. 230 |
Coal Workers' Lung Diseases and Silicosis | p. 238 |
Occupational Asthma, Byssinosis, and Industrial Bronchitis | p. 250 |
Toxic Inhalations | p. 257 |
Indoor and Outdoor Air Pollution | p. 275 |
Pulmonary Disorders Related to High Altitude | p. 285 |
Diving Injuries and Air Embolism | p. 292 |
Thermal Lung Injury and Acute Smoke Inhalation | p. 297 |
Drug-Induced Lung Diseases | p. 307 |
Drug-Induced Lung Disease due to Nonchemotherapeutic Agents | p. 309 |
Pulmonary Toxicity Associated with Chemotherapeutic Agents | p. 327 |
Interstitial and Inflammatory Lung Diseases | p. 337 |
Interstitial Lung Disease: A Clinical Overview and General Approach | p. 339 |
Systemic Sarcoidosis | p. 348 |
Idiopathic Pulmonary Fibrosis | p. 360 |
Hypersensitivity Pneumonitis | p. 373 |
Radiation Pneumonitis | p. 381 |
Pulmonary Manifestations of the Collagen Vascular Diseases | p. 390 |
The Eosinophilic Pneumonias | p. 408 |
Pulmonary Histiocytosis X | p. 423 |
Pulmonary Lymphagioleiomyomatosis and Tuberous Sclerosis | p. 429 |
The Lungs in Patients with Inborn Errors of Metabolism | p. 434 |
Alveolar Diseases | p. 441 |
Alveolar Hemorrhage Syndromes | p. 443 |
Pulmonary Alveolar Proteinosis | p. 449 |
Disorders of the Pulmonary Circulation | p. 451 |
Pulmonary Hypertension and Cor Pulmonale | p. 453 |
Pulmonary Thromboembolic Disease | p. 461 |
Pulmonary Edema | p. 469 |
Pulmonary Vasculitis | p. 477 |
Pulmonary Arteriovenous Malformations | p. 482 |
Disorders of the Pleural Space | p. 485 |
Pleural Effusions: Nonmalignant and Malignant | p. 487 |
Pneumothorax | p. 507 |
Malignant Mesothelioma and Other Primary Pleural Tumors | p. 513 |
Diseases of the Mediastinum | p. 519 |
The Mediastinum: Overview, Anatomy, and Diagnostic Approach | p. 521 |
Disorders of the Chest Wall and Neuromuscular Diseases | p. 535 |
Disorders of the Chest Wall | p. 537 |
Neuromuscular Diseases | p. 545 |
Sleep and Sleep Disorders | p. 561 |
Sleepiness, Control of Ventilation and Sleep-Disorders Breathing | p. 563 |
Surgical Aspects of Pulmonary Medicine | p. 575 |
Surgical Aspects of Pulmonary Medicine | p. 577 |
Thoracic Trauma | p. 585 |
Lung Transplantation | p. 593 |
Neoplasms of the Lungs | p. 605 |
The Solitary Pulmonary Nodule: A Systemic Approach | p. 607 |
Non-Small Cell Lung Cancer - Clinical Aspects, Diagnosis, Staging, and Treatment | p. 615 |
Lung Tumors Other Than Bronchogenic Carcinoma: Benign, Malignant, and Metastatic | p. 642 |
Extrapulmonary Syndromes Associated with Lung Tumors | p. 652 |
Infectious Diseases of the Lungs | p. 659 |
Approach to the Patient with Pulmonary Infection | p. 661 |
Antimicrobial Therapy of Common Pulmonary Infections | p. 700 |
Community-Acquired Pneumonia | p. 715 |
Nosocomial Respiratory Tract Infections and Gram-Negative Pneumonia | p. 734 |
Mycobacterial Infections | p. 763 |
Fungal Infections of the Lungs | p. 820 |
Viral Infections of the Lungs and Respiratory Tract | p. 887 |
Parasitic Infections of the Lungs | p. 912 |
Pulmonary Infection in Immunocompromised Hosts | p. 941 |
Zoonotic and Unusual Pneumonias | p. 997 |
Acute Respiratory Failure | p. 1021 |
Acute Respiratory Distress Syndrome | p. 1023 |
Systemic Inflammatory Response and Multiple Organ Dysfunction Syndromes | p. 1029 |
Acute Respiratory Failure in the Surgical Patient | p. 1034 |
Respiratory Distress Syndrome of the Newborn | p. 1044 |
Oxygen Therapy and Pulmonary Oxygen Toxicity | p. 1049 |
Intubation and Upper Airway Management | p. 1058 |
Hemodynamic and Respiratory Monitoring in Acute Respiratory Failure | p. 1064 |
Mechanical Ventilation | p. 1073 |
Nutrition in Acute Respiratory Failure | p. 1082 |
Sedation and Analgesia in the Intensive Care Unit | p. 1090 |
Pulmonary Pharmacotherapy | p. 1099 |
Ethics in Critical Care | p. 1111 |
Agents Potentially Associated with Bioterrorism | p. 1115 |
Index | p. 1123 |
Table of Contents provided by Blackwell. All Rights Reserved. |